Figures & data
Table 1 Baseline physical and physiological characteristics of subjects
Fig. 1 Flow chart of the trial protocol
Fig. 2 Total leukocyte 1(a), neutrophil 1(b), lymphocyte 1(c), and monocyte 1(d) counts before and immediately after exercise at 85% V̇O2,peak or 85% V̇O2,max after four-week placebo (PLA) and cashew apple juice (CAJ) supplementation. Values are mean ± SE, n = 10 in each group. # significantly different from PLA supplementation at the same condition, p < 0.05, ¶ significantly different from before exercise at the same condition, p < 0.05
Fig. 3 Plasma MDA concentrations before and immediately after exercise at 85% V̇O2,peak or 85% V̇O2,max after four-week placebo (PLA) and cashew apple juice (CAJ) supplementation. Values are mean ± SD, n = 10 in each group. MDA, malaondialdehyde. * Significantly different from before supplementation, p < 0.05, # significantly different from PLA supplementation, p < 0.05, @ significantly different from untrained group, p < 0.05. ¶ significantly different from before exercise at the same condition, p < 0.05
Fig. 4 Plasma 8-isoprostane concentrations before and immediately after exercise at 85% V̇O2,peak or 85% V̇O2,max after 4-week placebo (PLA) and cashew apple juice (CAJ) supplementation. Values are mean ± SD, n = 10 in each group. * Significantly different from before supplementation, p < 0.05, # significantly different from PLA supplementation, p < 0.05. ¶ significantly different from before exercise at the same condition, p < 0.05
Fig. 5 Plasma cortisol concentrations before and immediately after exercise at 85% V̇O2,peak or 85% V̇O2,max after four-week placebo (PLA) and cashew apple juice (CAJ) supplementation. Values are mean ± SD, n = 10 in each group. # significantly different from PLA supplementation, p < 0.05
Availability of data and materials
Data are presented in the manuscript, further information available upon request.